These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38518551)

  • 1. Upping the ante: enhanced expression of interferon-antagonizing ORF6 and ORF9b proteins by SARS-CoV-2 variants of concern.
    Caobi A; Saeed M
    Curr Opin Microbiol; 2024 Jun; 79():102454. PubMed ID: 38518551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis.
    Kehrer T; Cupic A; Ye C; Yildiz S; Bouhaddou M; Crossland NA; Barrall EA; Cohen P; Tseng A; Çağatay T; Rathnasinghe R; Flores D; Jangra S; Alam F; Mena I; Aslam S; Saqi A; Rutkowska M; Ummadi MR; Pisanelli G; Richardson RB; Veit EC; Fabius JM; Soucheray M; Polacco BJ; Ak B; Marin A; Evans MJ; Swaney DL; Gonzalez-Reiche AS; Sordillo EM; van Bakel H; Simon V; Zuliani-Alvarez L; Fontoura BMA; Rosenberg BR; Krogan NJ; Martinez-Sobrido L; García-Sastre A; Miorin L
    Cell Host Microbe; 2023 Oct; 31(10):1668-1684.e12. PubMed ID: 37738983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING signaling pathways.
    Han L; Zhuang MW; Deng J; Zheng Y; Zhang J; Nan ML; Zhang XJ; Gao C; Wang PH
    J Med Virol; 2021 Sep; 93(9):5376-5389. PubMed ID: 33913550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of enhanced innate immune evasion by SARS-CoV-2.
    Thorne LG; Bouhaddou M; Reuschl AK; Zuliani-Alvarez L; Polacco B; Pelin A; Batra J; Whelan MVX; Hosmillo M; Fossati A; Ragazzini R; Jungreis I; Ummadi M; Rojc A; Turner J; Bischof ML; Obernier K; Braberg H; Soucheray M; Richards A; Chen KH; Harjai B; Memon D; Hiatt J; Rosales R; McGovern BL; Jahun A; Fabius JM; White K; Goodfellow IG; Takeuchi Y; Bonfanti P; Shokat K; Jura N; Verba K; Noursadeghi M; Beltrao P; Kellis M; Swaney DL; García-Sastre A; Jolly C; Towers GJ; Krogan NJ
    Nature; 2022 Feb; 602(7897):487-495. PubMed ID: 34942634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists.
    Yuen CK; Lam JY; Wong WM; Mak LF; Wang X; Chu H; Cai JP; Jin DY; To KK; Chan JF; Yuen KY; Kok KH
    Emerg Microbes Infect; 2020 Dec; 9(1):1418-1428. PubMed ID: 32529952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO.
    Wu J; Shi Y; Pan X; Wu S; Hou R; Zhang Y; Zhong T; Tang H; Du W; Wang L; Wo J; Mu J; Qiu Y; Yang K; Zhang LK; Ye BC; Qi N
    Cell Rep; 2021 Feb; 34(7):108761. PubMed ID: 33567255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 ORF6 protein does not antagonize interferon signaling in respiratory epithelial Calu-3 cells during infection.
    Li M; Ayyanathan K; Dittmar M; Miller J; Tapescu I; Lee JS; McGrath ME; Xue Y; Vashee S; Schultz DC; Frieman MB; Cherry S
    mBio; 2023 Aug; 14(4):e0119423. PubMed ID: 37377442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 variants evolve convergent strategies to remodel the host response.
    Bouhaddou M; Reuschl AK; Polacco BJ; Thorne LG; Ummadi MR; Ye C; Rosales R; Pelin A; Batra J; Jang GM; Xu J; Moen JM; Richards AL; Zhou Y; Harjai B; Stevenson E; Rojc A; Ragazzini R; Whelan MVX; Furnon W; De Lorenzo G; Cowton V; Syed AM; Ciling A; Deutsch N; Pirak D; Dowgier G; Mesner D; Turner JL; McGovern BL; Rodriguez ML; Leiva-Rebollo R; Dunham AS; Zhong X; Eckhardt M; Fossati A; Liotta NF; Kehrer T; Cupic A; Rutkowska M; Mena I; Aslam S; Hoffert A; Foussard H; Olwal CO; Huang W; Zwaka T; Pham J; Lyons M; Donohue L; Griffin A; Nugent R; Holden K; Deans R; Aviles P; Lopez-Martin JA; Jimeno JM; Obernier K; Fabius JM; Soucheray M; Hüttenhain R; Jungreis I; Kellis M; Echeverria I; Verba K; Bonfanti P; Beltrao P; Sharan R; Doudna JA; Martinez-Sobrido L; Patel AH; Palmarini M; Miorin L; White K; Swaney DL; Garcia-Sastre A; Jolly C; Zuliani-Alvarez L; Towers GJ; Krogan NJ
    Cell; 2023 Oct; 186(21):4597-4614.e26. PubMed ID: 37738970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated temperature inhibits SARS-CoV-2 replication in respiratory epithelium independently of IFN-mediated innate immune defenses.
    Herder V; Dee K; Wojtus JK; Epifano I; Goldfarb D; Rozario C; Gu Q; Da Silva Filipe A; Nomikou K; Nichols J; Jarrett RF; Stevenson A; McFarlane S; Stewart ME; Szemiel AM; Pinto RM; Masdefiol Garriga A; Davis C; Allan J; Graham SV; Murcia PR; Boutell C
    PLoS Biol; 2021 Dec; 19(12):e3001065. PubMed ID: 34932557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deubiquitinase USP1 regulates sarbecovirus ORF6 protein function.
    Gao W; Wang L; Cui W; Wang H; Huang G; Li Z; Li G; Zhang W
    J Virol; 2024 Jan; 98(1):e0143723. PubMed ID: 38084957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2-mediated evasion strategies for antiviral interferon pathways.
    Oh SJ; Shin OS
    J Microbiol; 2022 Mar; 60(3):290-299. PubMed ID: 35122601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type I and III interferon responses in SARS-CoV-2 infection.
    Kim YM; Shin EC
    Exp Mol Med; 2021 May; 53(5):750-760. PubMed ID: 33953323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Deubiquitinase USP29 Promotes SARS-CoV-2 Virulence by Preventing Proteasome Degradation of ORF9b.
    Gao W; Wang L; Ju X; Zhao S; Li Z; Su M; Xu J; Wang P; Ding Q; Lv G; Zhang W
    mBio; 2022 Jun; 13(3):e0130022. PubMed ID: 35638730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic functional analysis of SARS-CoV-2 proteins uncovers viral innate immune antagonists and remaining vulnerabilities.
    Hayn M; Hirschenberger M; Koepke L; Nchioua R; Straub JH; Klute S; Hunszinger V; Zech F; Prelli Bozzo C; Aftab W; Christensen MH; Conzelmann C; Müller JA; Srinivasachar Badarinarayan S; Stürzel CM; Forne I; Stenger S; Conzelmann KK; Münch J; Schmidt FI; Sauter D; Imhof A; Kirchhoff F; Sparrer KMJ
    Cell Rep; 2021 May; 35(7):109126. PubMed ID: 33974846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 Variant Delta Potently Suppresses Innate Immune Response and Evades Interferon-Activated Antiviral Responses in Human Colon Epithelial Cells.
    Tandel D; Sah V; Singh NK; Potharaju PS; Gupta D; Shrivastava S; Sowpati DT; Harshan KH
    Microbiol Spectr; 2022 Oct; 10(5):e0160422. PubMed ID: 36073824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Cullin 5-based complex serves as an essential modulator of ORF9b stability in SARS-CoV-2 replication.
    Zhou Y; Chen Z; Liu S; Liu S; Liao Y; Du A; Dong Z; Zhang Y; Chen X; Tao S; Wu X; Razzaq A; Xu G; Tan DA; Li S; Deng Y; Peng J; Dai S; Deng X; Zhang X; Jiang T; Zhang Z; Cheng G; Zhao J; Xia Z
    Signal Transduct Target Ther; 2024 Jun; 9(1):159. PubMed ID: 38937432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 ORF6 Disrupts Bidirectional Nucleocytoplasmic Transport through Interactions with Rae1 and Nup98.
    Addetia A; Lieberman NAP; Phung Q; Hsiang TY; Xie H; Roychoudhury P; Shrestha L; Loprieno MA; Huang ML; Gale M; Jerome KR; Greninger AL
    mBio; 2021 Apr; 12(2):. PubMed ID: 33849972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple E3 ligases act as antiviral factors against SARS-CoV-2 via inducing the ubiquitination and degradation of ORF9b.
    Yu M; Li J; Gao W; Li Z; Zhang W
    J Virol; 2024 Jun; 98(6):e0162423. PubMed ID: 38709105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 Isolates Show Impaired Replication in Human Immune Cells but Differential Ability to Replicate and Induce Innate Immunity in Lung Epithelial Cells.
    Jiang M; Kolehmainen P; Kakkola L; Maljanen S; Melén K; Smura T; Julkunen I; Österlund P
    Microbiol Spectr; 2021 Sep; 9(1):e0077421. PubMed ID: 34378952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic innate immune response determines susceptibility to SARS-CoV-2 infection and early replication kinetics.
    Cheemarla NR; Watkins TA; Mihaylova VT; Wang B; Zhao D; Wang G; Landry ML; Foxman EF
    J Exp Med; 2021 Aug; 218(8):. PubMed ID: 34128960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.